Efficacy of human umbilical cord mesenchymal stem cell in the treatment of neuromyelitis optica spectrum disorders: an animal study
Abstract Background Human umbilical cord mesenchymal stem cells (hUC-MSCs) have great potential for treating autoimmune diseases for their immunomodulatory and tissue-regenerative abilities; however, their therapeutic role in neuromyelitis optica spectrum disorder (NMOSD) remains uncertain. Methods...
Saved in:
| Main Authors: | Chunran Xue, Haojun Yu, Xuzhong Pei, Xiaoying Yao, Jie Ding, Xiying Wang, Yi Chen, Yangtai Guan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Stem Cell Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-025-04187-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders
by: A. N. Boyko, et al.
Published: (2021-10-01) -
Neuromyelitis Optica Spectrum Disorder: A Case Report
by: Paulius Sėdžius, et al.
Published: (2024-12-01) -
Neuromyelitis Optica (NMO) — Study Review
by: Justyna Chojdak-Łukasiewicz
Published: (2021-06-01) -
Complement inhibition rapidly blocks lesion extension and facilitates remyelination in neuromyelitis optica
by: Katherine S Given, et al.
Published: (2025-06-01) -
Cognitive impairment in neuromyelitis optica spectrum disorders
by: E. A. Vekhina, et al.
Published: (2024-06-01)